| Control | Experimental | p-value |
---|---|---|---|
N = 15 | N = 15 | ||
Median (IQR) | |||
Age, years | 60 (52–68) | 61 (53–68) | 0.68a |
BMI, kg/m2 | 23.53 (22.22–28.52) | 22.03 (21.48–24.49) | 0.20a |
Duration of stroke, years | 1.5 (1.08–2.33) | 2.5 (1.08–5.17) | 0.23a |
 | Control | Experimental | p-value |
---|---|---|---|
N (%) | |||
Gender | |||
 Female | 6 (40%) | 6 (40%) | 1.00b |
 Male | 9 (60%) | 9 (60%) |  |
Side of stroke | |||
 Left | 7 (46.67%) | 9 (60%) | 0.46b |
 Right | 8 (53.33%) | 6 (40%) |  |
Type of stroke | |||
 Hemorrhagic | 6 (40%) | 7 (46.67%) | 0.71b |
 Ischemic | 9 (60%) | 8 (53.33%) |  |
Br. stage (U/E) | |||
 II | 0 (0%) | 2 (13.33%) | 0.06c |
 III | 3 (20%) | 6 (40%) |  |
 IV | 10 (66.67%) | 3 (20%) |  |
 V | 2 (13.33%) | 4 (26.67%) |  |
Br. stage (L/E) | |||
 III | 4 (26.67%) | 3 (20%) | 0.80c |
 IV | 8 (53.33%) | 7 (46.67%) |  |
 V | 3 (20%) | 5 (33.33%) |  |